Practice patterns and resources are not well established for patients with less common cancers such as myelofibrosis. Community cancer programs may be challenged to keep up with evolving treatments, new anti-cancer medications, and the availability of clinical trials for patients with myelofibrosis.
Providers in smaller cancer programs may see just a few patients with myelofibrosis each year, keeping up with rapidly changing treatment options can be a challenge. Providers can contact ACCC Community Resource Centers for myelofibrosis to ask peer-to-peer questions and gain support.
Watch our video and learn more.